Phosphatidyltransferase GDR (ASRT1): a potential drug target (G5729)

Target Name: PTGDR

NCBI ID: G5729

PTGDR

Phosphatidyltransferase GDR (ASRT1): a potential drug target

introduction

Phosphatidyltransferase GDR (ASRT1) is an intracellular protein that is responsible for the transfer of phosphatidylcholine (PA) within cells. PA is an important neurotransmitter that plays a key role in communication between neurons. ASRT1 plays a key role in neuronal survival and synaptic transmission and is therefore considered an important target in the fields of neuroscience and drug development.

Biological functions of ASRT1

The main function of ASRT1 in neurons is to promote PA transfer. PA is a key substance in information transmission between neurons. Through the transfer of ASRT1, neurons can quickly recognize and respond to different neural signals. ASRT1 transfers PA from one organelle to another through a series of phosphorylation, thereby achieving rapid delivery of PA.

The role of ASRT1 in neuronal death

ASRT1 plays an important role in neuronal death. During the process of neuronal apoptosis, the phosphorylation of ASRT1 changes. Changes in phosphorylation sites can lead to loss of function of ASRT1, leading to neuronal apoptosis. Therefore, the role of ASRT1 in neuronal death is of great significance for understanding the molecular mechanism of neuronal apoptosis.

ASRT1 and neuroscience

The importance of ASRT1 in neuroscience research is self-evident. ASRT1 is an important intracellular biomarker in neurons. By studying the function of ASRT1, scientists can gain an in-depth understanding of the physiological and pathological processes of neurons. In addition, ASRT1 can also be used as a drug target, providing new ideas for drug research and development.

The relationship between ASRT1 and drug development

The importance of ASRT1 in drug development has received increasing attention. As a potential drug target, ASRT1 has high drug development value. Currently, ASRT1 has become a hot topic in many drug research, and many scientists are committed to studying the role of ASRT1 in drugs and looking for the possibility of ASRT1 as a drug target.

Therapeutic prospects of ASRT1

ASRT1 has broad application prospects in drug research and development. As an important biomarker, ASRT1 can be used to monitor the health of neurons, thereby providing an important basis for the diagnosis of neuronal diseases. In addition, ASRT1 can also be used as a drug target, providing new ideas for drug research and development. In the future, ASRT1 is expected to become an effective means of treating neuronal diseases.

in conclusion

ASRT1 is an intracellular protein responsible for the transfer of phosphatidylcholine (PA) within neurons. ASRT1 plays a key role in neuronal survival and synaptic transmission and is therefore considered an important target in the fields of neuroscience and drug development. With the deepening of ASRT1 research, ASRT1 is expected to become an effective means to treat neuronal diseases and bring good news to human health.

Protein Name: Prostaglandin D2 Receptor

Functions: Receptor for prostaglandin D2 (PGD2). The activity of this receptor is mainly mediated by G(s) proteins that stimulate adenylate cyclase, resulting in an elevation of intracellular cAMP. A mobilization of calcium is also observed, but without formation of inositol 1,4,5-trisphosphate (By similarity). Involved in PLA2G3-dependent maturation of mast cells. PLA2G3 is secreted by immature mast cells and acts on nearby fibroblasts upstream to PTDGS to synthesize PGD2, which in turn promotes mast cell maturation and degranulation via PTGDR (By similarity)

The "PTGDR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTGDR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets